Patents by Inventor James G. Heffernan

James G. Heffernan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibody - platinum co-ordination compound complex
    Patent number: 4956454
    Abstract: Platinum co-ordination compounds comprising at least one amine ligand and a functional group remotely bonded to the amine ligand, which functional group may be linkable to a monoclonal antibody to provide a moiety which stabilizes the antibody against in vivo hydrolysis.
    Type: Grant
    Filed: April 21, 1988
    Date of Patent: September 11, 1990
    Assignee: Johnson Matthey PLC
    Inventors: James G. Heffernan, Paul C. Hydes, Donald H. Picker
  • Monoclonal antibody-platinum co-ordination compound complex
    Patent number: 4952676
    Abstract: A platinum co-ordination compound linkable to a monoclonal antibody by a functional group which forms part of a moiety which stabilizes the antibody against in vivo hydrolysis. Also the use of such compounds in the treatment of cancer.
    Type: Grant
    Filed: July 20, 1988
    Date of Patent: August 28, 1990
    Assignee: Johnson Matthey PLC
    Inventors: James G. Heffernan, Michael J. Cleare, Donald H. Picker
  • Platinum co-ordination compounds
    Patent number: 4760156
    Abstract: A platinum co-ordination compound linkable to a monoclonal antibody by a functional group which forms part of a moiety which stabilises the antibody against in vivo hydrolysis. Also the use of such compounds in the treatment of cancer.
    Type: Grant
    Filed: June 11, 1986
    Date of Patent: July 26, 1988
    Inventors: James G. Heffernan, Michael J. Cleare, Donald H. Picker
  • Platinum co-ordination compounds
    Patent number: 4760155
    Abstract: Platinum co-ordination compounds comprising at least one amine ligand and a functional group remotely bonded to the amine ligand, which functional group may be linkable to a monoclonal antibody to provide a moiety which stabilizes the antibody against in vivo hydrolysis.
    Type: Grant
    Filed: June 11, 1986
    Date of Patent: July 26, 1988
    Inventors: James G. Heffernan, Paul C. Hydes, Donald H. Picker